On the contrary, DNA methylation at the MB-COMT promoter, as well as the anti-inflammatory actions exerted by IFN-γ, might hold clinical relevance in patients with CFS/FM. The gene discussed is COMT; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.